Concepedia

Jeewon Chon

JC

Statistics

Publications

1

Citations

51

H-Index

1

Active since

2018

Affiliations

Vanderbilt University Medical Center(Current)

Jeewon Chon is an author at Vanderbilt University Medical Center specializing in programmed cell death protein 1 inhibitors, braf v600 mutations, and pharmacotherapy.

ORCID

Publications per year

2018–2018

1

Publications

1

Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1‐based therapy

Karim R. Saab, Meghan J. Mooradian, Daniel Wang et al. · Cancer · 2018 · 51 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

1–1 of 1